BioNexus Gene Lab Corp Common stockBGLC

Capital at risk.

About BioNexus Gene Lab Corp Common stock
Ticker
info
BGLC
Trading on
info
NASDAQ
ISIN
info
-
Industry
info
Specialty Chemicals
Sector
info
Basic Materials
CEO
info
Su-Leng Tan
Headquarters
info
Tower B, Avenue 3, Kuala Lumpur, undefined, Malaysia, 59200
Employees
info
30
Website
info
bionexusgenelab.com
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Metrics
BasicAdvanced
Market cap
info
$5.2M
P/E ratio
info
-
EPS
info
-$0.06
Dividend Yield
info
0.00%
Beta
info
1.69
Forward P/E ratio
info
0
EBIDTA
info
$-0.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$5.2M
Average daily volume
info
0.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.56
Price to book
info
0.55
Earnings
EPS
info
-$0.06
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-0.3M
Revenues (TTM)
info
$9.3M
Revenues per share (TTM)
info
$0.52
Technicals
Beta
info
1.69
52-week High
info
$1.00
52-week Low
info
$0.21
50-day moving average
info
$0.36
200-day moving average
info
$0.39
Short ratio
info
3.48
Short %
info
2.04%
Management effectiveness
ROE (TTM)
info
9.87%
ROA (TTM)
info
2.29%
Profit margin
info
10.17%
Gross profit margin
info
$1.2M
Operating margin
info
50.85%
Growth
Quarterly earnings growth (YoY)
info
95.00%
Quarterly revenue growth (YoY)
info
3.00%
Share stats
Outstanding Shares
info
18M
Float
info
12.4M
Insiders %
info
51.38%
Institutions %
info
0.99%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.02
-
-
Q4 • 23Beat
-$0.01
-
-
Q1 • 24Beat
$0.01
-
-
Q2 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$2M
$0.2M
10.08%
Q2 • 24
$2.6M
$-1.3M
51.15%
Q3 • 24
33.21%
775.71%
607.24%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$11.1M
$1.6M
14.31%
Q2 • 24
$11M
$1.6M
14.61%
Q3 • 24
1.30%
0.81%
2.14%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-0.7M
$0.1M
$0.2M
$-0.7M
Q2 • 24
$-1.5M
$-0.2M
$-0.2M
$-1.7M
Q3 • 24
117.66%
320.46%
213.68%
150.43%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a BioNexus Gene Lab Corp Common stock share?
Collapse

BioNexus Gene Lab Corp Common stock shares are currently traded for undefined per share.

How many shares does BioNexus Gene Lab Corp Common stock have?
Collapse

BioNexus Gene Lab Corp Common stock currently has 18M shares.

Does BioNexus Gene Lab Corp Common stock pay dividends?
Collapse

No, BioNexus Gene Lab Corp Common stock doesn't pay dividends.

What is BioNexus Gene Lab Corp Common stock 52 week high?
Collapse

BioNexus Gene Lab Corp Common stock 52 week high is $1.00.

What is BioNexus Gene Lab Corp Common stock 52 week low?
Collapse

BioNexus Gene Lab Corp Common stock 52 week low is $0.21.

What is the 200-day moving average of BioNexus Gene Lab Corp Common stock?
Collapse

BioNexus Gene Lab Corp Common stock 200-day moving average is $0.39.

Who is BioNexus Gene Lab Corp Common stock CEO?
Collapse

The CEO of BioNexus Gene Lab Corp Common stock is Su-Leng Tan.

How many employees BioNexus Gene Lab Corp Common stock has?
Collapse

BioNexus Gene Lab Corp Common stock has 30 employees.

What is the market cap of BioNexus Gene Lab Corp Common stock?
Collapse

The market cap of BioNexus Gene Lab Corp Common stock is $5.2M.

What is the P/E of BioNexus Gene Lab Corp Common stock?
Collapse

The current P/E of BioNexus Gene Lab Corp Common stock is null.

What is the EPS of BioNexus Gene Lab Corp Common stock?
Collapse

The EPS of BioNexus Gene Lab Corp Common stock is -$0.06.

What is the PEG Ratio of BioNexus Gene Lab Corp Common stock?
Collapse

The PEG Ratio of BioNexus Gene Lab Corp Common stock is null.